SCHEMBL25329987

SCHEMBL25329987

Cc1cc(Br)cc(O)c1C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.64
ACHE P22303 2/20 0.64
MAPK1 P28482 3/20 0.49
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 2/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
POLB P06746 2/20 0.47
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
DHODH Q02127 1/20 0.40
LDHA P00338 2/20 0.40
LDHB P07195 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
G6PD P11413 1/20 0.40
RECQL P46063 1/20 0.40
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL596184 0.87 CYP3A4 (0.50) CYP3A4ACHEMAPK1ALDH1A1KMT2A
SCHEMBL15523819 0.84 CA1 (0.50) CYP3A4ACHEMAPK1ALDH1A1KMT2A
SCHEMBL20561796 0.79 CYP3A4 (0.68) CYP3A4ACHEMAPK1ALDH1A1KMT2A
Orsellinic Acid SCHEMBL522294 0.78 CYP3A4 (1.00) CYP3A4ACHEMAPK1ALDH1A1KMT2A
SCHEMBL3469028 0.78 CYP3A4 (0.69) CYP3A4ACHEMAPK1ALDH1A1KMT2A
SCHEMBL3835523 0.78 CYP3A4 (0.42) CYP3A4ACHEMAPK1ALDH1A1KMT2A
SCHEMBL29803911 0.78 CYP3A4 (0.42) CYP3A4ACHEMAPK1ALDH1A1HSD17B10
SCHEMBL22060772 0.78 CYP3A4 (0.42) CYP3A4ACHEMAPK1ALDH1A1KMT2A
SCHEMBL1727042 0.78 CYP3A4 (0.42) CYP3A4ACHEMAPK1ALDH1A1HSD17B10
SCHEMBL1104465 0.78 ALDH1A1 (0.48) CYP3A4ACHEMAPK1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4466260-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2024-11-27 EP disclosed
CN-118574821-A Compounds and their use in the treatment of cancer 阿斯利康(瑞典)有限公司 2024-08-30 CN disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed